Array Biopharma

Why Array BioPharma Inc. Sank 13.5% in May
Motley Fool
Wed, 06/7/17 - 10:08 am
Array Biopharma
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
binimetinib
encorafenib
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
Will Array Biopharma's Melanoma Drugs Keep the Stock Soaring?
Motley Fool
Wed, 03/22/17 - 10:55 pm
Array Biopharma
melonoma
Array walks back its FDA pitch on binimetinib, derailing plans for commercial launch
Endpoints
Mon, 03/20/17 - 09:35 am
Array Biopharma
FDA
binimetinib
NRAS-positive melanoma
melanoma
3 Cancer Drugs That Could Get an FDA OK Next Year
Motley Fool
Mon, 10/10/16 - 09:02 am
FDA
rucaparib
Clovis Oncology
ovarian cancer
binimetinib
Array Biopharma
melanoma
brigatinib
Ariad Pharmaceuticals
non-small cell lung cancer
Top 6 Biopharma Gainers of the Past Week
24/7 Wall St
Tue, 10/4/16 - 10:20 am
Catabasis
Sarepta Therapeutics
Anavex
Biogen
Array Biopharma
GW Pharma
3 Biotechs That Could Be M&A Targets
Motley Fool
Sat, 09/24/16 - 01:40 pm
biotech
M&A
cancer
Seattle Genetics
Array Biopharma
Clovis Oncology
Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
Wed, 09/14/16 - 11:53 pm
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
Array Bio ends late-stage study of ovarian cancer drug
Yahoo/Reuters
Fri, 04/1/16 - 10:16 am
Array Biopharma
clinical trials
ovarian cancer
binimetinib
Amgen, Inc, Celgene Corporation Can Find Array Biopharma Inc Attractive
Bidness, ETC
Mon, 12/21/15 - 02:57 pm
Amgen
Celgene
Array Biopharma
Array Biopharma melanoma drug succeeds in late-stage study
Yahoo/Reuters
Wed, 12/16/15 - 10:09 am
Array Biopharma
melanoma
binimetinib
3 Low-Price Biotech Stocks That Could Pop or Drop in 2016
Motley Fool
Fri, 08/21/15 - 08:50 am
Agenus
Array Biopharma
Idera Pharmaceuticals
4 Speculative Biotechs With Huge Analyst Targets
24/7 Wall St
Sat, 05/9/15 - 12:06 pm
biotech
Array Biopharma
Onconova
Tonix Pharmaceuticals
XTL Bipharmaceuticals
The 3 Best Biotech Stocks Of The Last 30 Days
Yahoo/Benzinga
Tue, 02/3/15 - 10:31 am
Array Biopharma
Tekmira
Ziopharm
Array shares jump after drugmaker details Novartis deal
Yahoo/AP
Fri, 01/23/15 - 03:27 pm
Array Biopharma
Novartis
encorafenib
binimetinib
cancer
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Array Biopharma Regains Rights to Cancer Drug From Novartis
TheStreet.com
Wed, 12/3/14 - 09:16 pm
Array Biopharma
Novartis
binimetinib
cancer
GSK
Eight Biotech Stocks Trading Near $5 With Huge Upside Potential
24/7 Wall St
Fri, 02/7/14 - 09:43 am
Array Biopharma
Biodel
Galena Biopharma
Novavax
Protalix BioTherapeutics
Rigel Pharmaceuticals
Synta Pharmaceuticals
Zogenix
Opportunities in Lung Cancer Therapies
Motley Fool
Sun, 11/24/13 - 12:30 pm
lung cancer
non-small cell lung cancer
Avastin
Genentech
Roche
Tarceva
AstraZeneca
Iressa
Alimta
selumetinib
Array Biopharma
CO-1686
Clovis Oncology
AP26113
Ariad Pharmaceuticals

Pages